Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
分子特征分析定义了第 4 组髓母细胞瘤内具有临床意义的异质性,并改善了疾病风险分层。
期刊:Acta Neuropathologica
影响因子:9.3
doi:10.1007/s00401-023-02566-0
Goddard, Jack; Castle, Jemma; Southworth, Emily; Fletcher, Anya; Crosier, Stephen; Martin-Guerrero, Idoia; García-Ariza, Miguel; Navajas, Aurora; Masliah-Planchon, Julien; Bourdeaut, Franck; Dufour, Christelle; Ayrault, Olivier; Goschzik, Tobias; Pietsch, Torsten; Sill, Martin; Pfister, Stefan M; Rutkowski, Stefan; Richardson, Stacey; Hill, Rebecca M; Williamson, Daniel; Bailey, Simon; Schwalbe, Edward C; Clifford, Steven C; Hicks, Debbie